Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Value of sFlt-1/PlGF Ratio for the Etiology of Intra Uterine Growth Restriction
NCT05151289Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2020
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: PlGF / sFlt-1 ratio and placental lesions to confirm the diagnosis of vascular intrauterine growth retardation. Started Jan 2020; status: completed.
Beyond the preview
Go deeper on NCT05151289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05151289.